Human breast cancer: Genetic alterations in the MET gene region

Clinical and Investigative Medicine

Volumn 19, Issue 4, 1996, Pages 222-230

  Tougas, Liette ^a   Halwani, Fawaz ^a   Tremblay, Gilles ^a   Sampalis, John ^a   Lin, Jenny ^a   Park, Morag ^a   Jothy, Serge ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CHROMOSOME 7Q; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2;

EID: 0029741224     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bièche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 1992;339:139-43.
2. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, et al. The mechanism of met oncogene activation. Cell 1986;45:895-904.
3. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude GF. Sequence of the met roto-oncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 1987;84:6379-83.
4. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM. Tyrosine kinase receptor indistinguishable from the c-Met protein. Nature 1989;339:155-6.
5. Park M, Testa JR, Blair DG, Parsa NZ, Vande Woude GF. Two rearranged met alleles in MNNG-HOS cells reveal the orientation of met on chromosome 7 to other markers tightly linked to the cystic fibrosis locus. Proc Natl Acad Sci USA 1988;85:2667-71.
6. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-4.
7. Tsarfaty I, Resau JH, Shen RL, Keydar I, Faletto DL, Vande Woude GF. The met proto-oncogene receptor and lumen formation. Science 1992;257:1258-61.
8. Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J. Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 1994;107:3557-68.
9. McGuire WL. Quantitation of estrogen receptor in mammary carcinoma. Methods Enzymol 1975;36:248-54.
10. Vindelov LL, Christensen U, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1994;3:323-7.
11. Estivill X, Farrall M, Scambler PJ, Bell GM, Hawley KMF, Lench NJ, et al. A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands. Nature 1987;326:840-5.
12. McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BMJ, et al. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. Cancer Res 1991;51:3296-303.
13. Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, et al. Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 1994;54:499-505.
14. Lasko D, Cavence W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991;25:281-314.
15. Fukuyama R, Ichijoh Y, Minoshima S, Kitamura N, Shimizu N. Regional localization of the hepatocyte growth factor (HGF) gene to human chromosome 7 band q21.1. Genomics 1991;11:410-5.
16. Liu C, Tsao MS. Expression of the epidermal growth factor receptor, c-erbB-2, and c-met genes in primary colorectal carcinomas. Cancer Res 1991;32:292
17. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993;55:72-5.
18. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991;6:1997-2003.